The prevalence and management of side effects of lithium and anticonvulsants as mood stabilizers in bipolar disorder from a clinical perspective: A review

International Clinical Psychopharmacology

Volumn 28, Issue 6, 2013, Pages 287-296

  Dols, Annemiek ^a   Sienaert, Pascal ^d   Van Gerven, Heleen ^b   Schouws, Sigfried ^a   Stevens, Anja ^c   Kupka, Ralph ^a   Stek, Max L ^a  

^a VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^b GGZ Dijk en Duin ^*  (Netherlands)

^c Dimence   (Netherlands)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

Mood stabilizer; Side effect; Treatment

Indexed keywords

CARBAMAZEPINE; LAMOTRIGINE; LITHIUM; VALPROIC ACID;

ACNE; BIPOLAR DISORDER; BLOOD DYSCRASIA; CLEFT PALATE; COGNITIVE DEFECT; CRANIOFACIAL SYNOSTOSIS; DIARRHEA; DRUG SAFETY; GLOMERULUS FILTRATION RATE; HAIR LOSS; HEART ATRIUM SEPTUM DEFECT; HEPATITIS; HUMAN; HYPERAMMONEMIA; HYPERTRANSAMINASEMIA; HYPOACTIVE SEXUAL DESIRE DISORDER; HYPOSPADIAS; HYPOTHYROIDISM; KIDNEY CONCENTRATING CAPACITY; KIDNEY FAILURE; META ANALYSIS; NAUSEA; POLYDACTYLY; POLYDIPSIA; POLYURIA; PRENATAL DRUG EXPOSURE; PREVALENCE; PRIORITY JOURNAL; PSORIASIS; REVIEW; SEXUAL DYSFUNCTION; SIDE EFFECT; SYSTEMATIC REVIEW; TERATOGENICITY; TREMOR; VOMITING; WEIGHT GAIN;

ANTICONVULSANTS; ANTIMANIC AGENTS; BIPOLAR DISORDER; COGNITION DISORDERS; DISEASE MANAGEMENT; GASTROINTESTINAL DISEASES; HUMANS; LITHIUM; PREVALENCE;

EID: 84885305401     PISSN: 02681315     EISSN: 14735857     Source Type: Journal    
DOI: 10.1097/YIC.0b013e32836435e2     Document Type: Review

References (122)

1. Adab N, Jacoby A, Smith D, Chadwick D (2001). Additional educational needs in children born to mothers with epilepsy. J Neurol Neurosurg Psychiatry 70:15-21
2. Aiken CB, Orr C (2010). Rechallenge with lamotrigine after a rash: A prospective case series and review of the literature. Psychiatry (Edgmont) 7:27-32
3. Aizenberg D, Sigler M, Zemishlany Z, Weizman A (1996). Lithium and male sexual function in affective patients. Clin Neuropharmacol 19:515-519
4. Akkerhuis GW, Nolen WA (2003). Lithium-Associated psoriasis and omega-3 fatty acids. Am J Psychiatry 160:1355
5. Askmark H, Wiholm BE (1990). Epidemiology of adverse reactions to carbamazepine as seen in a spontaneous reporting system. Acta Neurol Scand 81:131-140
6. Barrueto F Jr, Hack JB (2001). Hyperammonemia and coma without hepatic dysfunction induced by valproate therapy. Acad Emerg Med 8:999-1001
7. Batlle DC, Von Riotte AB, Gaviria M, Grupp M (1985). Amelioration of polyuria by amiloride in patients receiving long-Term lithium therapy. N Engl J Med 312:408-414
8. Bedford JJ, Weggery S, Ellis G, McDonald FJ, Joyce PR, Leader JP, et al. (2008). Lithium-induced nephrogenic diabetes insipidus: Renal effects of amiloride. Clin J Am Soc Nephrol 3:1324-1331
9. Bendz H, Sjondin I, Aurell M (1996). Renal function on and off lithium in patients treated with lithium for 15 years or more. A controlled, prospective lithiumwithdrawal study. Nephrol Dial Transplant 11:457-460
10. Bendz H, Aurell M (1999). Drug-induced diabetes insipidus: Incidence, prevention and management. Drug Saf 21:449-456
11. Bendz H, Aurell M, Lanke J (2001). A historical cohort study of kidney damage in long-Term lithium patients: Continued surveillance needed. Eur Psychiatry 16:199-206
12. Bertolino JG (1990). Carbamazepine. What physicians should know about its hematologic effects. Postgrad Med 88:183-186
13. Bocchetta A, Loviselli A (2006). Lithium treatment and thyroid abnormalities. Clin Pract Epidemiol Ment Health 2:23
14. Bocchetta A, Cocco F, Velluzzi F, Del Zompo M, Mariotti S, Loviselli A (2007). Fifteen-year follow-Up of thyroid function in lithium patients. J Endocrinol Invest 30:363-366
15. Boton R, Gaviria M, Batlle DC (1987). Prevalence, pathogenesis, and treatment of renal dysfunction associated with chronic lithium therapy. Am J Kidney Dis 10:329-345
16. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, et al. (1994). Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA 271:918-924
17. Bowden CL, Calabrese JR, McElroy SL, Gyulai L, Wassef A, Petty F, et al. (2000). A randomized, placebo-controlled 12-month trial of divalproex and lithium in treatment of outpatients with bipolar I disorder. Divalproex Maintenance Study Group. Arch Gen Psychiatry 57:481-489
18. Bowden CL (2003). Valproate. Bipolar Disord 5:189-202
19. Bowden CL, Calabrese JR, Ketter TA, Sachs GS, White RL, Thompson TR (2006). Impact of lamotrigine and lithium on weight in obese and nonobese patients with bipolar I disorder. Am J Psychiatry 163:1199-1201
20. Brewerton TD (1986). Lithium counteracts carbamazepine-induced leukopenia while increasing its therapeutic effect. Biol Psychiatry 21:677-685
21. Bucht G, Wahlin A (1980). Renal concentrating capacity in long-Term lithium treatment and after withdrawal of lithium. Acta Med Scand 207:309-314
22. Burgess A, Geddes J, Hwaton K, Townsend E, Jamison K, Goodwin G (2001). Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev 3:CD003013
23. Calabrese JR, Sullivan JR, Bowden CL, Suppes T, Goldberg JF, Sachs GS, et al. (2002). Rash in multicenter trials of lamotrigine in mood disorders: Clinical relevance and management. J Clin Psychiatry 63:1012-1019
24. Chicharro AV, De Marinis AJ, Kanner AM (2007). The measurement of ammonia blood levels in patients taking valproic acid: Looking for problems where they do not exist? Epilepsy Behav 11:361-366
25. Cohen LS, Friedman JM, Jefferson JW, Johnson EM, Weiner ML (1994). A reevaluation of risk of in utero exposure to lithium. JAMA 271:146-150
26. Cohen LS (2007). Treatment of bipolar disorder during pregnancy. J Clin Psychiatry 68 (Suppl 9):4-9
27. Cox M, Singer I (1975). Lithium and water metabolism. Am J Med 59:153-157
28. Cunnington MC, Weil JG, Messenheimer JA, Ferber S, Yerby M, Tennis P (2011). Final results from 18 years of the International Lamotrigine Pregnancy Registry. Neurology 76:1817-1823
29. Daban C, Martinez-Aran A, Torrent C, Sanchez-Moreno J, Goikolea JM, Benabarre A, et al. (2006). Cognitive functioning in bipolar patients receiving lamotrigine: Preliminary results. J Clin Psychopharmacol 26:178-181
30. Dealberto MJ (2007). Valproate-induced hyperammonaemic encephalopathy: Review of 14 cases in the psychiatric setting. Int Clin Psychopharmacol 22:330-337
31. Demyttenaere K, De Fruyt J, Sienaert P (1998). Psychotropics and sexuality. Int Clin Psychopharmacol 13 (Suppl 6):S35-S41
32. Diaz VV, Balanzá -Martinez V, Soeiro-De-Souza MG, Moreno RA, Figueira ML, Machado-Vieira R, et al. (2012). Pharmalogical approaches in bipolar disorders and the impact on cognition: A critical review. Acta Psychiatr Scand 126:315-331
33. Fenn HH, Sommer BR, Ketter TA, Alldredge B (2006). Safety and tolerability of mood-stabilising anticonvulsants in the elderly. Expert Opin Drug Saf 5:401-416
34. Forlenza OV, Diniz BS, Radanovic M, Santos FS, Talib LL, Gattaz WF (2011). Disease-modifying properties of long-Term lithium treatment for amnestic mild cognitive impairment: Randomised controlled trial. Br J Psychiatry 198: 351-356
35. Gau CS, Chang CJ, Tsai FJ, Chao PF, Gau SS (2010). Association between mood stabilizers and hypothyroidism in patients with bipolar disorders: A nested, matched case-control study. Bipolar Disord 12:253-263
36. Gelenberg AJ, Jefferson JW (1995). Lithium tremor. J Clin Psychiatry 56: 283-287
37. Ghadirian AM, Ananble L, Belanger MC (1992). Lithium, benzodiazepines, and sexual function in bipolar patients. Am J Psychiatry 149:801-805
38. Ghose K (1991). The need for a review journal of drug use and the elderly. Drugs Aging 1:2-5
39. Ghozzi H, Hakim A, Sahnoun Z, Ben Mahmoud L, Atheymen R, Hammami S, et al. (2011). Relationship between plasma concentrations of valproic acid and hepatotoxicity in patients receiving high doses. Rev Neurol (Paris) 167: 600-606
40. Goodwin FK, Jamison KR, Ghaemi SN (2007). Manic-Depressive illness: Bipolar disorders and recurrent depression. New York; Oxford: Oxford University Press
41. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller HJ, Kasper S (2013). The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: Update 2012 on the long-Term treatment of bipolar disorder. World J Biol Psychiatry 14: 154-219
42. Hallam K (2010). Managing the impact of mood stabiliser-induced tremors in patients with bipolar disorder. Acta Neuropsychiatr 22:259-260
43. Harden CL (2008). Sexual dysfunction in women with epilepsy. Seizure 17: 131-135
44. Herzog AG, Drislande FW, Schomer DL, Pennell PB, Bromfield EB, Dworetzky BA, et al. (2005). Differential effects of antiepileptic drugs on sexual function and hormones in men with epilepsy. Neurology 65:1016-1020
45. Hillemacher T, Bleich S, Kornhuber J, Frieling H (2006). Hair loss as a side effect of lamotrigine treatment. Am J Psychiatry 163:1451
46. Holt R, Maunder E (1996). Is lithium-induced weight gain prevented by providing healthy eating advice at the commencement of lithium therapy? J Hum Nutr Diet 9:127-133
47. Hung CC, Li TM, Wei IH, Huang CC (2011). The real mechanism of VPA-induced hyperammonemia remains unknown. Gen Hosp Psychiatry 33:e3-e4
48. Husain AM, Carwille ST, Miller PP, Radker RA (2000). Improved sexual function in three men taking lamotrigine for epilepsy. South Med J 93:335-336
49. Jafferany M (2008). Lithium and skin: Dermatologic manifestations of lithium therapy. Int J Dermatol 47:1101-1111
50. Jentink J, Dolk H, Loane MA, Morris JK, Wellesley D, Garne E, De Jong van den Berg L (2010a). Intrauterine exposure to carbamazepine and specific congenital malformations: Systematic review and case-control study. BMJ 341:c6581
51. Jentink J, Loane MA, Dolk H, Barisic I, Garne E, Morris JK, De Jong van den Berg L (2010b). Valproic acid monotherapy in pregnancy and major congenital malformations. N Engl J Med 362:2185-2193
52. Joffe RT, MacDonald C, Kutcher SP (1988). Lack of differential cognitive effects of lithium and carbamazepine in bipolar affective disorder. J Clin Psychopharmacol 8:425-428
53. Johnston AM, Eagles JM (1999). Lithium-Associated clinical hypothyroidism. Prevalence and risk factors. Br J Psychiatry 175:336-339
54. Johnson FR, Ozdemor S, Manjunath R, Hauber AB, Burch SP, Thompson TR (2007). Factors that affect adherence to bipolar disorder treatments: A stated-preference approach. Med Care 45:545-552
55. Jones KL, Lacro RV, Johnson KA, Adams J (1989). Pattern of malformations in the children of women treated with carbamazepine during pregnancy. N Engl J Med 320:1661-1666
56. Kalapos MP (2002). Carbamazepine-provoked hepatotoxicity and possible aetiopathological role of glutathione in the events. Retrospective review of old data and call for new investigation. Adverse Drug React Toxicol Rev 21:123-141
57. Kallen B, Tandberg A (1983). Lithium and pregnancy. A cohort study on manicdepressive women. Acta Psychiatr Scand 68:134-139
58. Keck PE, Mc Elroy SL (2003). Bipolar disorder, obesity, and pharmacotherapyassociated weight gain. J Clin Psychiatry 64:1426-1435
59. Keranen T, Sivenius J (1983). Side effects of carbamazepine, valproate and clonazepam during long-Term treatment of epilepsy. Acta Neurol Scand Suppl 97:69-80
60. Kessing LV, Forman JL, Andersen PK (2010). Does lithium protect against dementia? Bipolar Disord 12:87-94
61. Ketter TA, Wang PW, Chandler RA, Alarcon AM, Becker OV, Nowakowska C, et al. (2005). Dermatology precautions and slower titration yield low incidence of lamotrigine treatment-emergent rash. J Clin Psychiatry 66: 642-645
62. Kirov G, Tredget J, John R, Owne MJ, Lazarus JH (2005). A cross-sectional and a prospective study of thyroid disorders in lithium-Treated patients. J Affect Disord 87:313-317
63. Kleiner J, Altshuler L, Hendrick V, Hershman JM (1999). Lithium-induced subclinical hypothyroidism: Review of the literature and guidelines for treatment. J Clin Psychiatry 60:249-255
64. Konovalov S, Muralee S, Tampi RR (2008). Anticonvulsants for the treatment of behavioral and psychological symptoms of dementia: A literature review. Int Psychogeriatr 20:293-308
65. Kupka RW, Nolen WA, Post RM, McElroy SL, Altshuler LL, Denicoff KD, et al. (2002). High rate of autoimmune thyroiditis in bipolar disorder: Lack of association with lithium exposure. Biol Psychiatry 51:305-311
66. Labiner DM (2002). Lamotrigine and rash: Scratching beneath the surface. J Clin Psychiatry 63:1010-1011
67. Lackmann GM (2004). Valproic-Acid-induced thrombocytopenia and hepatotoxicity: Discontinuation of treatment? Pharmacology 70:57-58
68. Lepkifker E, Sverdlik A, Iancu I, Ziv R, Segev S, Kotler M (2004). Renal insufficiency in long-Term lithium treatment. J Clin Psychiatry 65:850-856
69. Mahmoud F, Tampi RR (2011). Valproic acid-induced parkinsonism in the elderly: A comprehensive review of the literature. Am J Geriatr Pharmacother 9: 405-412
70. Malhi GS, Tanious M (2011). Optimal frequency of lithium administration in the treatment of bipolar disorder: Clinical and dosing considerations. CNS Drugs 25:289-298
71. Manjunath G, Tighiouart H, Ibrahim H, MacLeod B, Salem DN, Griffith JL, et al. (2003). Level of kidney function as a risk factor for atherosclerotic cardiovascular outcomes in the community. J Am Coll Cardiol 41:47-55
72. Markowitz GS, Radhakrishnan J, Kambham N, Valeri AM, Hines WH, D'Agati VD (2000). Lithium nephrotoxicity: A progressive combined glomerular and tubulointerstitial nephropathy. J Am Soc Nephrol 11:1439-1448
73. Martinez-Aran A, Vieta E, Colom F, Torrent C, Reinares M, Goikolea JM, et al. (2005). Do cognitive complaints in euthymic bipolar patients reflect objective cognitive impairment? Psychother Psychosom 74:295-302
74. McKinney PA, Finkenbine RD, Devane CL (1996). Alopecia and mood stabilizer therapy. Ann Clin Psychiatry 8:183-185
75. McKnight RF, Adida M, Budge K, Stockton S, Goodwin GM, Geddes JR (2012). Lithium toxicity profile: A systematic review and meta-Analysis. Lancet 379:721-728
76. Mercier-Guidez E, Loas G (1998). Polydipsia: Review of the literature. Encephale 24:223-229
77. Mercke Y, Sheng H, Khan T, Lippmann S (2000). Hair loss in psychopharmacology. Ann Clin Psychiatry 12:35-42
78. Miodownik C, Witztum E, Lerner V (2002). Lithium-induced tremor treated with vitamin B6: A preliminary case series. Int J Psychiatry Med 32:103-108
79. Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J (2005). Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology 64:1134-1138
80. Nemeroff CB (2003). Safety of available agents used to treat bipolar disorder: Focus on weight gain. J Clin Psychiatry 64:532-539
81. Nguyen HT, Sharma V, McIntyre RS (2009). Teratogenesis associated with antibipolar agents. Adv Ther 26:281-294
82. Nora JJ, Nora AH, Toews WH (1974). Letter: Lithium, Ebstein's anomaly, and other congenital heart defects. Lancet 2:594-595
83. Oh SH, Kim DS, Kwon YS, Lee JH, Lee KH (2008). Concurrence of palmoplantar psoriasiform eruptions and hair loss during carbamazepine treatment. Acta Derm Venereol 88:532-533
84. Pachet AK, Wisniewski AM (2003). The effects of lithium on cognition: An updated review. Psychopharmacology (Berl) 170:225-234
85. Pande AC, Max P, Donnelly RF (1986). Lithium associated with psoriasis. J Clin Psychiatry 47:330
86. Patrizi A, Savoia F, Negosanti F, Posar A, Santucci M, Neri I (2005). Telogen effluvium caused by magnesium valproate and lamotrigine. Acta Derm Venereol 85:77-78
87. Perkins DO (2002). Predictors of noncompliance in patients with schizophrenia. J Clin Psychiatry 63:1121-1128
88. Pijl H, Meinders AE (1996). Bodyweight change as an adverse effect of drug treatment. Mechanisms and management. Drug Saf 14:329-342
89. Pompili M, Serafini G, Del Casale A, Rigucci S, Innamorati M, Girardi P, et al. (2009). Improving adherence in mood disorders: The struggle against relapse, recurrence and suicide risk. Expert Rev Neurother 9:985-1004
90. Presne C, Fakhouri F, Noel LH, Stengel B, Even C, Kreis H, et al. (2003). Lithiuminduced nephropathy: Rate of progression and prognostic factors. Kidney Int 64:585-592
91. Rej S, Herrmann N, Shulman K (2012). The effects of lithium on renal function in older adults -A systematic review. J Geriatr Psychiatry Neurol 25:51-61
92. Remmer HI, Falk WE (1986). Successful treatment of lithium-induced acne. J Clin Psychiatry 47:48
93. Rubinsztein JS, Michale A, Paykel ES, Sahakian BJ (2000). Cognitive impairment in remission in bipolar affective disorder. Psychol Med 30:1025-1036
94. Sachs GS, Guille C (1999). Weight gain associated with use of psychotropic medications. J Clin Psychiatry 60 (Suppl 21):16-19
95. Sajatovic M, Blow FC (2007). Bipolar disorder in later life. Baltimore, MD: Johns Hopkins University Press
96. Schouws SN, Stek ML, Comijs HC, Beekman AT (2010). Risk factors for cognitive impairment in elderly bipolar patients. J Affect Disord 125: 330-335
97. Senturk V, Goker C, Bilgic A, Olmez S, Tugcu H, Oncu B, et al. (2007). Impaired verbal memory and otherwise spared cognition in remitted bipolar patients on monotherapy with lithium or valproate. Bipolar Disord 9 (Suppl 1):136-144
98. Seo HJ, Chiesa A, Lee SJ, Patkar AA, Han C, Masand PS, et al. (2011). Safety and tolerability of lamotrigine: Results from 12 placebo-controlled clinical trials and clinical implications. Clin Neuropharmacol 34:39-47
99. Shan JC, Hsieh MH, Liu CC, Wen CC, Liu CM (2009). Clinical alertness to valproic acid-induced hyperammonemia -Two case reports. J Psychopharmacol 24:943-945
100. Sienaert P, De Fruyt J (2001). Sexual side effects of psychopharmaca. Ann Psychiatry Psychother 2002:265-278
101. Smaldone M, Sukkarieh T, Reda A, Khan A (2004). Epilepsy and erectile dysfunction: A review. Seizure 13:453-459
102. Sobotka JL, Alexander B, Cook BL (1990). A review of carbamazepine's hematologic reactions and monitoring recommendations. DICP 24: 1214-1219
103. Stoll AL, McElroy SL (1991). Histamine2-receptor antagonists for the treatment of valproate-induced gastrointestinal distress. Ann Clin Psychiatry 3:301-304
104. Szupera Z (2007). The role of the antiepileptic drugs at the development of the sexual dysfunctions in male epileptic patients. Ideggyogy Sz 60:4-13
105. Tengstrand M, Star K, Van Puijenbroek EP, Hill R (2010). Alopecia in association with lamotrigine use: An analysis of individual case safety reports in a global database. Drug Saf 33:653-658
106. Tomson T, Battino D (2008). Teratogenic effects of antiepileptic drugs. Seizure 17:166-171
107. Torrent C, Amann B, Sanchez-Moreno J, Colom F, Reinares M, Comes M, et al. (2008). Weight gain in bipolar disorder: Pharmacological treatment as a contributing factor. Acta Psychiatr Scand 118:4-18
108. Van Melick EJ, Wilting I, Meinders AE, Egberts TC (2010). Prevalence and determinants of thyroid disorders in elderly patients with affective disorders: Lithium and nonlithium patients. Am J Geriatr Psychiatry 18:395-403
109. Velligan DI, Weiden PJ, Sajatovic M, Scott J, Carpenter D, Ross R, Docherty JP (2010). Assessment of adherence problems in patients with serious and persistent mental illness: Recommendations from the Expert Consensus Guidelines. J Psychiatr Pract 16:34-45
110. Verrotti A, D'Egidio C, Mohn A, Coppola G, Parisi P, Chiarelli F (2011). Antiepileptic drugs, sex hormones, and PCOS. Epilepsia 52:199-211
111. Vestergaard P, Amdisen A (1981). Lithium treatment and kidney function. A follow-Up study of 237 patients in long-Term treatment. Acta Psychiatr Scand 63:333-345
112. Vestergaard P, Poulstrip I, Schou M (1988). Prospective studies on a lithium cohort. 3. Tremor, weight gain, diarrhea, psychological complaints. Acta Psychiatr Scand 78:434-441
113. Wilting I, Heerdink ER, Mersch PP, den Boer JA, Egberts AC, Nolen WA (2009). Association between lithium serum level, mood state, and patient-reported adverse drug reactions during long-Term lithium treatment: A naturalistic follow-Up study. Bipolar Disord 11:434-440
114. Wingo AP, Harvey PD, Baldessarini RJ (2009). Neurocognitive impairment in bipolar disorder patients: Functional implications. Bipolar Disord 11:113-125
115. Wood IK, Parmelee DX, Foreman JW (1989). Lithium-induced nephrotic syndrome. Am J Psychiatry 146:84-87
116. Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Beaulieu S, Alda M, et al. (2013). Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: Update 2013. Bipolar Disord 15:1-44
117. Yeung CK, Chan HH (2004). Cutaneous adverse effects of lithium: Epidemiology and management. Am J Clin Dermatol 5:3-8
118. Yonkers KA, Wisner KL, Stowe Z, Leibenluft E, Cohen L, Miller L, et al. (2004). Management of bipolar disorder during pregnancy and the postpartum period. Am J Psychiatry 161:608-620
119. Young RC, Murphy CF, Heo M, Schulberg HC, Alexopoulos GS (2006). Cognitive impairment in bipolar disorder in old age: Literature review and findings in manic patients. J Affect Disord 92:125-131
120. Zimmermann U, Rechlin T, Plaskacewicz GJ, Barocka A, Wildt L, Kaschka WP (1997). Effect of naltrexone on weight gain and food craving induced by tricyclic antidepressants and lithium: An open study. Biol Psychiatry 41: 747-749
121. Zubieta JK, Huguelet P, O'Neil RL, Giordani BJ (2001). Cognitive function in euthymic bipolar I disorder. Psychiatry Res 102:9-20
122. Zuncheddu C, Carpiniello B (2006). Sexual dysfunctions and bipolar disorder: A study of patients submitted to a long-Term lithium treatment. Clin Ter 157:419-424